UNLOXCYT (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma Special meeting of stockholders to vote on Merge ...

Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May ...

Management highlighted continued focus on rate increases and underwriting adjustments in Casualty lines to address rising auto severity. Rate increases of 15% for personal umbrella and 17% for ...

Here's Seattle's projected safety depth chart to begin the 2025 season. Note: Macdonald has stated in the past that his scheme doesn't use the typical "free safety" and "strong safety" positions.

CNH and Starlink Logos CNH expands connectivity solutions with SpaceX’s Starlink CNH's New Holland and Case IH brands' ...

Q1 2025 net revenue of $20.4 million, driven by product net revenue of $17.2 million Completed sale of PRV for gross proceeds of $150 million, positioning balance sheet to drive the Company’s ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

China’s government is considering suspending its 125% tariff on some US imports, Bloomberg reported, citing sources familiar with the matter. This potential exemption would include medical equipment ...

A 2024 systematic review found that dance can be as effective or more effective than other forms of physical activity ... can increase a person’s heart rate. This helps to get more oxygen ...